Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COX8C pseudogene 1 (COX8CP1) is a processed pseudogene—that is, a genomic DNA sequence similar to a protein-coding gene but typically without the ability to produce a functional protein product[1][2]. Pseudogenes like COX8CP1 generally arise via duplication or retrotransposition events, resulting in copies that accumulate mutations rendering them transcriptionally or translationally inactive[1]. Many pseudogenes, in general, were long considered "junk DNA," but some are now recognized to have biological roles at the RNA level, such as producing non-coding RNAs that may regulate their parent genes through mechanisms such as acting as microRNA decoys or influencing mRNA stability[1][2]. However, there is no published evidence of COX8CP1 itself having a specific biological function or being implicated as a therapeutic target or biomarker, and it does not interact with drugs nor present direct safety or therapeutic challenges. COX8CP1 should not be confused with protein-coding subunits of cytochrome c oxidase, which are true molecular targets or disease-related factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COX8C pseudogene 1 (COX8CP1).